Chapel Hill, NC, United States of America

Elizabeth Ann Vasievich

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Elizabeth Ann Vasievich

Introduction

Elizabeth Ann Vasievich is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of biotechnology, particularly in the area of immune response activation. With a total of 3 patents to her name, her work is recognized for its innovative approaches to enhancing immune cell functionality.

Latest Patents

Among her latest patents is a groundbreaking composition and method for stimulating an immune response using enantiomers of cationic lipids. This invention includes a composition that activates immune cells ex-vivo or induces an immune response in a subject. The composition comprises at least one chiral cationic lipid, which is characterized by a nonsteroidal cationic lipid structure. The chiral cationic lipid features a quaternary ammonium group and a spacer selected from various options, including hydrocarbon chains, esters, ketones, and peptides. This innovative approach aims to enhance the efficacy of immune responses in therapeutic applications.

Career Highlights

Elizabeth is currently associated with PDS Biotechnology Corporation, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing exploration of immune therapies and their applications in medicine.

Collaborations

Elizabeth has collaborated with notable colleagues, including Kenya N Toney Johnson and Gregory Conn. These partnerships have contributed to the success and impact of her innovative projects.

Conclusion

Elizabeth Ann Vasievich stands out as a leading inventor in the biotechnology sector, with her patents reflecting her commitment to advancing immune response technologies. Her contributions are shaping the future of therapeutic interventions in immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…